Latest News

Stay up to date with the latest stock market news from around the world. From breaking news written by our finance analysts to event-driven market news on a global scale.

NasdaqGS:RAIL
NasdaqGS:RAILMachinery

FreightCar America (RAIL) Q4 Loss Tests Bullish Margin Narrative Despite TTM Profitability

FreightCar America (RAIL) closed FY 2025 with Q4 revenue of US$125.6 million and a basic EPS loss of US$0.50, alongside trailing twelve month EPS of US$1.16 on revenue of US$501.0 million. Over the past six reported quarters, quarterly revenue has ranged from US$96.3 million to US$160.5 million, while basic EPS has swung between a profit of US$1.54 and a loss of US$3.57. This sets up a story of improving profitability on a full year view but mixed quarterly execution. That level of earnings...
NYSE:NL
NYSE:NLCommercial Services

NL Industries (NL) Earnings Swing To Loss Challenges Bullish Narratives On Profitability

NL Industries (NL) closed out FY 2025 with Q4 revenue of US$37.7 million and a basic EPS loss of US$0.63, alongside net income excluding extra items of a US$31.0 million loss that puts margins firmly under pressure. The company has seen quarterly revenue move from US$38.4 million in Q4 2024 to US$37.7 million in Q4 2025, while basic EPS shifted from US$0.34 to a loss of US$0.63. That swing matters if you are focused on the trajectory of earnings power. With trailing 12 month net income...
NYSE:MTN
NYSE:MTNHospitality

Vail Resorts (MTN) Q2 Net Margin Compression Tests Bullish Earnings Narrative

Vail Resorts (MTN) has just posted its Q2 2026 numbers, reporting revenue of US$1,083.9 million and basic EPS of US$5.87, alongside trailing twelve month EPS of US$6.38 on revenue of US$2.9 billion. The company’s quarterly revenue moved from US$1,137.2 million and EPS of US$6.54 in Q2 2025 to US$1,083.9 million and EPS of US$5.87 in Q2 2026. The latest trailing figures are in focus for investors considering how earnings power holds up across seasons. With net profit margins easing over the...
ASX:PNR
ASX:PNRMetals and Mining

Is Pantoro Gold (ASX:PNR) Still Attractive After Recent Share Price Pullback

If you are wondering whether Pantoro Gold is still good value after a strong run, this article walks through the key numbers so you can judge the price tag for yourself. The share price last closed at A$3.79, with returns of 53.8% over 1 year and a very large gain over 3 years, even though the stock has seen a 33.6% decline over 7 days, a 15.0% decline over 30 days and a 26.6% decline year to date. Recent coverage of Pantoro Gold has focused on how gold producers are being reassessed by...
NasdaqGS:FULT
NasdaqGS:FULTBanks

Fulton Financial HR Shift Puts Focus On Execution And Culture

Fulton Financial (NasdaqGS:FULT) has announced the retirement of Chief Human Resources Officer Bernadette Taylor. Karen Grafje, an internal leader with extensive industry experience, has been promoted to Chief Human Resources Officer. The transition places Grafje in a key role overseeing talent, culture, and workforce initiatives across the company. For investors tracking Fulton Financial at a share price of $20.01, this leadership change follows a mixed stretch of recent stock performance...
SGX:U14
SGX:U14Real Estate

Should UOL Group's Stronger 2025 Results and S$0.18 Dividend Require Action From UOL Group (SGX:U14) Investors?

UOL Group Limited has reported past full-year 2025 results, with sales of S$3.23 billion and net income of S$481.73 million, alongside basic and diluted earnings per share of S$0.57 from continuing operations. The company also affirmed an annual dividend of S$0.18 per share, signalling management’s willingness to return cash to shareholders following the stronger revenue and profit performance. Next, we’ll consider how UOL’s improved earnings and affirmed S$0.18 dividend shape its investment...
NYSE:ADCT
NYSE:ADCTBiotechs

ADC Therapeutics (ADCT) Loss Narrowing To US$0.04 EPS Challenges Bearish Profitability Narrative

ADC Therapeutics (ADCT) closed out FY 2025 with Q4 revenue of US$23.1 million and a basic EPS loss of US$0.04, alongside net income excluding extra items of a US$6.4 million loss. The company has seen quarterly revenue move from US$16.9 million in Q4 2024 to US$23.1 million in Q4 2025, while basic EPS losses shifted from US$0.29 to US$0.04 over the same period. This sets the stage for investors to focus on how these headline figures translate into the quality and direction of margins. See our...
SGX:C52
SGX:C52Transportation

ComfortDelGro (SGX:C52) Valuation Check After Share Buybacks And Stronger Full Year 2025 Results

ComfortDelGro (SGX:C52) has started repurchasing its own shares under a shareholder approved mandate, shortly after reporting full year 2025 sales of S$5,058.6m and net income of S$230.3m, drawing fresh attention to the stock. See our latest analysis for ComfortDelGro. At a share price of S$1.43, ComfortDelGro’s recent 1 day share price return of 0.70% and 7 day return of 4.03% decline sit against a 1 year total shareholder return of 4.84% and 3 year total shareholder return of 45.06%. This...
TSX:CAE
TSX:CAEAerospace & Defense

CAE Reshapes Defense Leadership To Pursue Cleaner Program Execution

CAE (TSX:CAE) has appointed Pascal Grenier as President, Defense & Security, marking a major leadership change in this core segment. The move is accompanied by immediate senior leadership reshuffling within Defense & Security. A key executive in the Defense & Security segment is departing the company as part of the changes. For you as an investor, this matters because Defense & Security is central to CAE's training and simulation business, which spans military aviation, mission systems, and...
OM:SINCH
OM:SINCHSoftware

How Sinch’s AI-Powered Voice Relay Launch At Sinch (OM:SINCH) Has Changed Its Investment Story

In early March 2026, Sinch AB (publ) unveiled new Enterprise Voice innovations at Enterprise Connect, including Voice Relay, which connects text-based AI agents directly to live phone calls and offloads complex real-time voice infrastructure for developers. This push to operationalize AI agents across global messaging, voice and email channels highlights Sinch's ambition to become core infrastructure for large-scale, AI-powered customer conversations. We’ll now explore how Sinch’s new...
TSE:8233
TSE:8233Multiline Retail

Takashimaya Company (TSE:8233) Valuation After Forecasting A Bond Cancellation Loss

Takashimaya Company (TSE:8233) has revised its earnings guidance for the fiscal year ending February 28, 2026, and now expects a loss attributable to owners of the parent after finalizing a large extraordinary loss on bond cancellation. See our latest analysis for Takashimaya Company. The guidance revision comes after a sharp 17.47% 1 month share price decline, even though the 1 year total shareholder return of 57.01% and 5 year total shareholder return of 230.47% point to strong longer term...
SEHK:2233
SEHK:2233Basic Materials

A Look At West China Cement (SEHK:2233) Valuation After Profit Guidance Forecasting 33% To 43% Growth

West China Cement (SEHK:2233) has issued fresh guidance, telling investors it expects profit attributable to shareholders for 2025 to be in the range of CN¥832.8 million to CN¥895.5 million, an increase of about 33% to 43% year on year. See our latest analysis for West China Cement. The guidance has arrived after a sharp pullback in the share price, with West China Cement closing at HK$2.21 following a 1 day share price return of 4.25%, yet posting a 30 day share price return of 23.79% and a...
NasdaqGM:VCEL
NasdaqGM:VCELBiotechs

Is Vericel (VCEL) Pricing Justified After A 30% One-Year Share Price Decline

If you are trying to work out whether Vericel is attractively priced today, it helps to step back and look at both its recent share performance and what the numbers say about value. Vericel shares last closed at US$34.12, with returns of 3.5% decline over 7 days, 5.7% decline over 30 days, a 4.2% decline year to date and a 30.2% decline over the last year, while the 3 year return is 15.3% and the 5 year return is 28% decline. Recent price moves sit against a backdrop of ongoing interest in...
TSX:CCL.B
TSX:CCL.BPackaging

CCL Industries (TSX:CCL.B) Balances Softer Earnings With Higher Dividend Hike – What Is Management Signalling?

CCL Industries Inc. recently reported its fourth-quarter and full-year 2025 results, with sales rising to CA$1,876.2 million for the quarter and CA$7.66 billion for the year, while net income eased to CA$171.1 million and CA$802.4 million respectively compared with the prior year. Alongside these results, CCL Industries announced a higher quarterly dividend of CA$0.36 per share payable on March 31, 2026, signalling continued emphasis on shareholder returns despite softer earnings. We’ll now...
SGX:F34
SGX:F34Food

Assessing Wilmar International’s (SGX:F34) Valuation After Stronger 2025 Sales And Earnings Results

Full year 2025 earnings put Wilmar in focus Wilmar International (SGX:F34) has drawn fresh attention after reporting full year 2025 results, with sales of US$70.4b and net income of US$1.41b, compared with US$67.4b and US$1.17b a year earlier. See our latest analysis for Wilmar International. The latest full year figures appear to have caught the market’s eye, with a 1 day share price return of 4.25% lifting Wilmar International to SGD3.68 and adding to a 90 day share price return of 21.05%...
NYSE:PINE
NYSE:PINEREITs

Should Alpine’s New High‑Coupon Mortgage Loan Strategy Shape How Investors View PINE’s Risk Profile?

Alpine Income Property Trust, Inc. recently originated a US$32.0 million first mortgage loan, funding US$8.6 million at close, to back the development of an 11‑acre, 101,000‑square‑foot retail center with investment grade tenants and three outparcels in the Covington Town Center master plan near Atlanta. The high‑coupon, 24‑month loan tied to a Target‑anchored project adjacent to an existing Publix highlights Alpine’s growing use of higher‑yield structured financing alongside its net lease...
NasdaqCM:RLMD
NasdaqCM:RLMDPharmaceuticals

A Look At Relmada Therapeutics (RLMD) Valuation After NDV‑01 Phase 2 Bladder Cancer Data

Phase 2 NDV-01 data and what it could mean for Relmada Therapeutics (RLMD) Relmada Therapeutics (RLMD) has drawn fresh attention after reporting 12 month interim Phase 2 data for NDV-01 in high risk non muscle invasive bladder cancer, showing strong complete response rates and a favorable safety profile. See our latest analysis for Relmada Therapeutics. The NDV-01 update and recent Leerink healthcare conference appearance came alongside a sharp shift in sentiment, with Relmada Therapeutics’ 1...
SEHK:215
SEHK:215Wireless Telecom

Hutchison Telecom (SEHK:215) Thin H1 Profit Tests Optimistic Turnaround Narratives

Hutchison Telecommunications Hong Kong Holdings (SEHK:215) posts modest FY 2025 first half profit Hutchison Telecommunications Hong Kong Holdings (SEHK:215) has released its FY 2025 first half results with revenue of HK$2,216 million and net income (excluding extra items) of HK$6 million, equal to basic EPS of HK$0.001245. The company’s half year revenue moved from HK$2,058 million in 2024 H1 to HK$2,724 million in 2024 H2 and HK$2,216 million in 2025 H1. Basic EPS shifted from a loss of...
OTCPK:TYFG
OTCPK:TYFGBanks

Tri-County Financial Group FY 2025 Margin Improvement Challenges Longer Term Profit Decline Narratives

Tri-County Financial Group (OTCPK:TYFG) has wrapped up FY 2025 with fourth quarter revenue of US$17.8 million and basic EPS of US$1.64, alongside trailing twelve month revenue of US$66.7 million and EPS of US$5.73 that sit against a 31% year over year earnings increase and a net profit margin of 20.5%. Over recent periods the company has seen revenue move from US$59.8 million and EPS of US$4.32 on a trailing basis in Q4 2024 to US$66.7 million and EPS of US$5.73 by Q4 2025, with margins...
SGX:D05
SGX:D05Banks

DBS Group (SGX:D05) Net Interest Margin Slip Challenges Premium Valuation Narrative

DBS Group Holdings (SGX:D05) has wrapped up FY 2025 with Q4 revenue of S$5.1b and basic EPS of S$0.78, alongside trailing twelve month revenue of S$22.1b and EPS of S$3.84 that frame the latest quarter against a fuller year of performance. Over the past year, total revenue on a trailing basis has moved from S$21.7b in FY 2024 to S$22.1b in FY 2025, while trailing net income excluding extra items went from S$11.2b to S$10.9b, giving investors a clear read on how top line growth and earnings...
NYSE:CURB
NYSE:CURBRetail REITs

Assessing Whether Curbline Properties (CURB) Is Mispriced After Recent Trading Moves

Why Curbline Properties Is On Investor Radar Today Curbline Properties (CURB) has drawn attention after recent trading left the stock with a 1 day return of 1.68% and a 7 day decline of 4.61%. This price movement has prompted fresh interest in its valuation. See our latest analysis for Curbline Properties. While the 7 day share price return of negative 4.61% has cooled sentiment, the 90 day share price return of 16.64% and 1 year total shareholder return of 18.72% point to momentum that has...
NasdaqGS:BCPC
NasdaqGS:BCPCChemicals

Balchem Launches Metalosate TEAM As Valuation And Growth Expectations Converge

Balchem has launched its Metalosate T.E.A.M. digital platform, a proprietary tool for advanced plant nutrition recommendations. The platform uses decades of company research to provide data driven micronutrient guidance for specialty crops. This free resource is aimed at helping advisors and growers refine yield, quality, and input efficiency during early and in-season planning. For investors watching Balchem (NasdaqGS:BCPC), the Metalosate T.E.A.M. launch adds a fresh development in the...
SWX:ROG
SWX:ROGPharmaceuticals

Is Roche Holding (SWX:ROG) Pricing In Too Much Pessimism After Recent Share Price Slide?

If you have been wondering whether Roche Holding shares are now offering good value or pricing in a lot of optimism, you are not alone. The stock last closed at CHF 332.40, with a 7 day return of an 8.4% decline, a 30 day return of a 6.7% decline, a 1 year return of 11.7% and a 3 year return of 40.4%. Recent moves in the share price sit against ongoing attention on Roche Holding as a major healthcare group, including continuing focus on its pharmaceuticals and diagnostics businesses and...
ASX:BC8
ASX:BC8Metals and Mining

Assessing Black Cat Syndicate (ASX:BC8) Valuation After A Turn To Profit And Strong Half Year Sales

Earnings jump puts Black Cat Syndicate (ASX:BC8) in focus Black Cat Syndicate (ASX:BC8) has drawn fresh attention after reporting half year sales of A$169.09 million and net income of A$34.58 million for the period ended December 31, 2025. This result contrasts with the same period a year earlier, when the company reported A$1.14 million in sales and a net loss of A$9.71 million, and shifts earnings per share into positive territory. See our latest analysis for Black Cat Syndicate. At a...